Significance of borderline HbA2 levels in β thalassemia carrier screening

[1]  A. Nadkarni,et al.  Borderline HbA2 levels: Dilemma in diagnosis of beta-thalassemia carriers. , 2021, Mutation research. Reviews in mutation research.

[2]  S. Pornprasert,et al.  Molecular Characterization of β- and α-Globin Gene Mutations in Individuals with Borderline Hb A2 Levels , 2020, Hemoglobin.

[3]  M. Cappellini,et al.  Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation , 2020, Drugs.

[4]  Richard Barnett.  Thalassaemia , 2019, The Lancet.

[5]  K. Ghosh,et al.  The phenotypic and molecular diversity of hemoglobinopathies in India: A review of 15 years at a referral center , 2018, International journal of laboratory hematology.

[6]  K. Ghosh,et al.  Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders. , 2019, Genomics.

[7]  J. Borgio,et al.  KLF1 gene and borderline hemoglobin A2 in Saudi population , 2017, Archives of medical science : AMS.

[8]  Roshan B. Colah,et al.  Burden of thalassemia in India: The road map for control , 2017 .

[9]  R. Bahar,et al.  The Diagnosis of Beta Thalassemia with Borderline HbA2 Level among Kelantan Population , 2017 .

[10]  S. Pornprasert,et al.  Detection of the common South-East Asian β0-thalassemia mutations in samples with borderline HbA2 levels , 2017, Clinical chemistry and laboratory medicine.

[11]  K. Ghosh,et al.  Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner , 2015, Prenatal Diagnosis.

[12]  D. Perrett,et al.  ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2 , 2015, International journal of laboratory hematology.

[13]  G. Garewal,et al.  Impact of iron deficiency on hemoglobin A2% in obligate β‐thalassemia heterozygotes , 2015, International journal of laboratory hematology.

[14]  S. Sharma,et al.  Interaction of Iron Deficiency Anemia and Hemoglobinopathies Among College Students and Pregnant Women: A Multi Center Evaluation in India , 2014, Hemoglobin.

[15]  K. Ghosh,et al.  Masking of a β-Thalassemia Determinant by a Novel δ-Globin Gene Defect [Hb A2-Saurashtra or δ100(G2)Pro→Ser; HBD: c.301C>T] in Cis , 2014, Hemoglobin.

[16]  S. Al Arrayed,et al.  Silent β-Thalassemia Mutations at −101 (C>T) and −71 (C>T) and Their Coinheritance with the Sickle Cell Mutation in Bahrain , 2013, Hemoglobin.

[17]  V. Viprakasit,et al.  Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand , 2013, Clinical chemistry and laboratory medicine.

[18]  M. Agarwal,et al.  Hemoglobin A2 Lowered by Iron Deficiency and α-Thalassemia: Should Screening Recommendation for β-Thalassemia Change? , 2013, ISRN hematology.

[19]  A. Giambona,et al.  Role of novel and rare nucleotide substitutions of the β-globin gene , 2012 .

[20]  K. Ghosh,et al.  Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[21]  Y. Aydinok.  Thalassemia , 2012, Hematology.

[22]  J. Hoyer,et al.  ICSH recommendations for the measurement of Haemoglobin A2 , 2012, International journal of laboratory hematology.

[23]  A. Gorakshakar,et al.  Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: Experiences from India , 2011, The Indian journal of medical research.

[24]  G. Fucharoen,et al.  Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand. , 2011, Blood cells, molecules & diseases.

[25]  D. Chui,et al.  New and Known β-Thalassemia Determinants Masked by Known and New δ Gene Defects [Hb A2-Ramallah or δ6(A3)Glu→Gln, GAG>>CAG] , 2010, Hemoglobin.

[26]  M. Moinuddin,et al.  Cap +1 mutation; an unsuspected cause of beta thalassaemia transmission in Pakistan. , 2009, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[27]  A. Maggio,et al.  The significance of the hemoglobin A(2) value in screening for hemoglobinopathies. , 2009, Clinical biochemistry.

[28]  A. Mosca,et al.  The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies , 2008, Journal of Clinical Pathology.

[29]  D. Mohanty,et al.  Prevalence and molecular characterization of alpha-thalassemia syndromes among Indians. , 2008, Genetic testing.

[30]  L. Romão,et al.  Mutational spectrum of delta‐globin gene in the Portuguese population , 2007, European journal of haematology.

[31]  A. Gorakshakar,et al.  HPLC studies in hemoglobinopathies , 2007, Indian journal of pediatrics.

[32]  A. Mosca,et al.  External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC systems , 2007, Clinical chemistry and laboratory medicine.

[33]  A. A. Abu Shahla,et al.  The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. , 2002, Clinical and laboratory haematology.

[34]  A. Cao,et al.  Genotype of subjects with borderline hemoglobin A2 levels: Implication for, β‐thalassemia carrier screening , 1994 .

[35]  M. Tzetis,et al.  The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece. , 1994, Hematologic pathology.

[36]  A. Cao,et al.  Hematological phenotype of the double heterozygous state for alpha and beta thalassemia. , 1984, Hemoglobin.